. Gonsette and . Rm, La Sclérose en plaques : Maladie, espoirs et réalité Editeur : Fondation Charcot. http://www.fondation-charcot.org/sitesThe first case history of multiple sclerosis, pp.1794-1848, 2010.

P. Kerschen-la-lettre-du-neurologue, pdf 4. F. Alfons Schelling. Carswell's classical 1838 Illustration of a peculiar diseased state of the spinal cord andpons http://www.ms-info.net/evo/msmanu/1022.htm 5. Fondation ArsepHistorique de la maladie". https://www.arsep.org/library/media/other/historique_de_la_sep.pdf 6. Patrick Hautecoeur Histoire de la sepA new mechanism of nervous system plasticity: activity-dependent myelination, Nature, vol.2, 2010.

B. Morrison, Oligodendroglia: metabolic supporters of axons, Trends in Cell Biology, vol.23, issue.12, 2013.
DOI : 10.1016/j.tcb.2013.07.007

S. Ravera and I. Et-panfoli, Role of myelin sheath energy metabolism in neurodegenerative diseases, Neural Regeneration Research, vol.10, issue.10, 2015.
DOI : 10.4103/1673-5374.167749

P. Morell and R. Quarles, Characteristic Composition of Myelin, 1999.

S. Schmitt, Metabolism and functions of lipids in myelin, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1851, issue.8, 2015.
DOI : 10.1016/j.bbalip.2014.12.016

A. Ishii, Human myelin proteome and comparative analysis with mouse myelin, Proceedings of the National Academy of Sciences, vol.5, issue.6, 2009.
DOI : 10.1074/mcp.M500162-MCP200

URL : http://www.pnas.org/content/106/34/14605.full.pdf

É. Larousse, Encyclopédie Larousse -sclérose en plaques. http://www.larousse.fr/encyclopedie/medical/sclérose_en_plaques/16025 14. HAS, Guide -Affection de longue durée -Sclérose en plaques, 2006.

S. Orton, Association of UV radiation with multiple sclerosis prevalence and sex ratio in France, Neurology, vol.76, issue.5, 2011.
DOI : 10.1212/WNL.0b013e31820a0a9f

URL : https://hal.archives-ouvertes.fr/hal-00567871

R. Milo and E. Kahana, Multiple sclerosis: Geoepidemiology, genetics and the environment, Autoimmunity Reviews, vol.9, issue.5, 2010.
DOI : 10.1016/j.autrev.2009.11.010

. R. Gosette, Sclérose en plaques : Maladie, espoirs et réalité Editeur : Fondation Charcot, page 9. http://www.fondation-charcot.org/sites/default/files/books/livrefr-fondation-charcot.pdf 18. Centre de référence des maladies neuro inflammatoires de l'enfant, Protocole National de Diagnostic et de Soins (PNDS) Sclérose en Plaques de l'enfant, 2016.

B. Popescu, Pathology of Multiple Sclerosis: Where Do We Stand? Contin Lifelong Learn Neurol, août 2013The relation between inflammation and neurodegeneration in multiple sclerosis brains, Sclérose en plaquespdf 22. Neuro-CEB, Don du cerveau post mortem pour la recherche scientifique, Les pathologies étudiées : la sclérose en plaques http, pp.2010-2011

B. Hemmer, NEW CONCEPTS IN THE IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS, Nature Reviews Neuroscience, vol.3, issue.4, 2002.
DOI : 10.1038/nrn784

C. Lucchinetti, Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis, Brain Pathology, vol.146, issue.3, 1996.
DOI : 10.1002/ana.410350105

C. Mainero, In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI, Neurology, vol.73, issue.12, 2009.
DOI : 10.1212/WNL.0b013e3181b64bf7

G. Ebers, Bientôt un traitement pour toutes les formes de la sclérose en plaques ? http://blog.servier.fr/bientot-un-traitement-pour-toutes-les-formes-de-la-sclerose-en-plaques/ 28. MSIF, "Formes évolutives de la SEPMS-in-focus-14-Disease-courses-French.pdf 29A genetic basis for familial aggregation in multiple sclerosis". Nature, 14 sept. 30. Novartis pharmaceuticals, rubrique Sclérose en plaquesGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, MS in focus n°14, 1932.

I. B. Zalc, La sclérose en plaques est une maladie auto-immune qui affecte le système nerveux central". 2014 http://www.inserm.fr/thematiques/neurosciences-sciences-cognitives-neurologie-psychiatrie/dossiers-d- information/sclerose-en-plaques-sep 33

T. V. Damotte and . Doctorale, Génétique de la sclérose en plaques : Héritabilité manquante et charge génétique, 2004.

C. Tao, Association between human herpesvirus & human endogenous retrovirus and MS onset & progression, Journal of the Neurological Sciences, vol.372
DOI : 10.1016/j.jns.2016.11.060

K. Munger and A. Ascherio, Risk factors in the development of multiple sclerosis, Expert Review of Clinical Immunology, vol.83, issue.5, 2007.
DOI : 10.1016/S0165-5728(97)00231-2

K. Munger, Anti-Epstein???Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel, Multiple Sclerosis Journal, vol.136, issue.10, 2011.
DOI : 10.1016/S1474-4422(09)70275-3

M. Barnett, Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: a reassessment. III: risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania, Journal of Neurology, vol.61, issue.2, 2016.
DOI : 10.1136/jnnp.2010.215186

A. Ascherio, Vitamin D and multiple sclerosisExplaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis, Lancet Neurol, 2009.

S. Ramagopalan, Rare variants in the CYP27B1 gene are associated with multiple sclerosis, Annals of Neurology, vol.96, issue.6, 2011.
DOI : 10.1210/jc.2010-1340

C. Hawkes, Smoking is a risk factor for multiple sclerosis: a metanalysis, Multiple Sclerosis Journal, vol.98, issue.5, 2007.
DOI : 10.1093/qjmed/hci135

A. Handel, Smoking and multiple sclerosis: an updated meta-analysis". PloS One, 2011.
DOI : 10.1371/journal.pone.0016149

URL : http://doi.org/10.1371/journal.pone.0016149

Y. Mikaeloff, Parental smoking at home and the risk of childhood-onset multiple sclerosis in childrenLa sclérose en plaques, Brain J Neurol. oct, vol.45, p.148, 1997.

A. Artemiadis, Stress as a Risk Factor for Multiple Sclerosis Onset or Relapse: A Systematic Review, Neuroepidemiology, vol.36, issue.2, 2011.
DOI : 10.1159/000323953

M. Topsoe and M. Et-jette-lautrup-frederiksen, Vaccines and multiple sclerosis: a systematic review http://resolver.ebscohost.com.gate2.inist.fr/openurl?sid=Entrez%3aPubMed&id=pmid%3a27604618&site=ftf- live 48. OMS, "Vaccin contre l'hépatite B et sclérose en plaques", extrait du rapport de la réunion du GACVS, Journal of Neurology, p.49, 2002.

M. Vichnin, An Overview of Quadrivalent Human Papillomavirus Vaccine Safety Collège des Enseignants de NeurologieSclérose en plaques", 2016. https://www.cenneurologie .fr/deuxi%C3%A8me-cycle%20/sclerose-plaques 51. GILLAIN.N, "L'analyse du LCR dans le diagnostic de la Sclérose en plaques, M. La sclérose en plaques, 2002.

V. Bianchi and W. Castro-borrero, Bruxelles: De Boeck; 2012. 54Current and emerging therapies in multiple sclerosis: a systematic review, Ther Adv Neurol Disord, juill 2012. 55. Caulin C, Vidal SA. Vidal Recos recommandations en pratique, 2014.

C. Madsen, The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis, Brain and Behavior, vol.12, issue.8, 2017.
DOI : 10.1517/13543784.12.4.689

B. Claire and . Thèse-d-'exercice-en-pharmacie, Traitements de la sclérose en plaques par la natalizumab: bilan d'utilisation et evaluation de la qualité, Sclérose en plaques, 2011.

J. Marriott, Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, vol.74, issue.18, 2010.
DOI : 10.1212/WNL.0b013e3181dc1ae0

C. Polman, A randomized 61. HASAubagio 14mg comprimé pelliculé Commission de la transparencePlacebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis Synthèse d'avis de la commission de la transparence : Lemtrada (alemtuzumab), janvier 2016. https://www.has-sante.fr/portail/upload/docs/applicationLes douleurs dans la sclérose en plaques". https://www.arsep.org/library/mediaThe future, N Engl J Med. N Engl J Med. ARSEP, Hautecoeur. P, vol.2, issue.20, 2006.

J. Salzer, Rituximab in multiple sclerosis, Neurology, vol.87, issue.20, pp.15-2016
DOI : 10.1212/WNL.0000000000003331

X. Montalban, Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis". The new england journal of medecineSphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis". CNS Drugs. juill 2015The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases, Clin Immunol, vol.69, 2017.

G. Comi, Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis, New England Journal of Medicine, vol.366, issue.11, pp.15-2012
DOI : 10.1056/NEJMoa1104318

URL : https://hal.archives-ouvertes.fr/hal-00826733

T. Vollmer, A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis, J Neurol, 2014.

F. Sedel, High doses of biotin in chronic progressive multiple sclerosis: A pilot studyMD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study SFEndocrino : Dosages d'hormones thyroïdiennes et biotine http, Mult Scler Relat Disord, vol.1

Z. Shao, LINGO-1 Regulates Oligodendrocyte Differentiation through the Cytoplasmic Gelsolin Signaling Pathway, The Journal of Neuroscience, vol.37, issue.12, pp.22-2017
DOI : 10.1523/JNEUROSCI.3722-16.2017

S. Jepson, Inhibits Oligodendrocyte Differentiation and Myelination through Intercellular Self-interactions Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis https://clinicaltrials.gov/ct2/show/NCT02040298 79 Ryan Rong WangHistamine H3 receptor negatively regulates oligodendrocyte differentiation and myelinisationLesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II studyRemyelination researchers regroup after proof-of-concept setback in multiple sclerosis, Transmembrane Signaling Protein, 2014.

I. Pirko, A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS, The FASEB Journal, 2004.
DOI : 10.1096/fj.04-2026fje

A. Mullin, rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelinationSEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease, Neurobiol Dis. Neurobiol Dis, 2015.

C. Laganke, Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trial, Neurology - Neuroimmunology Neuroinflammation, vol.4, issue.4, pp.16-2017
DOI : 10.1212/NXI.0000000000000367

. Geneuro, En savoir plus à propos de la SEP et du rétrovirus MSRV" http://www.geneuro.ch/fr/technologies- fr/domaine-therapeutique/sep-msrv 87. Nash RA, et al. High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS, Neurology, 2017.

P. Muraro, Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis, JAMA Neurology, vol.74, issue.4, 2017.
DOI : 10.1001/jamaneurol.2016.5867

P. Connick, Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study". Lancet Neurol. févr 2012. 90. Dulamea AMesenchymal stem cells in multiple sclerosis -translation to clinical trials"Thérapies par cellules souches dans la sep, J Med Life, 2012.

N. Allen, B. Barres, and A. Nishiyama, Neuroscience: Glia, more than just brain glue". Nature. février 2009. 93Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity, Nat Rev Neurosci, 2009.
DOI : 10.1038/457675a

W. Richardson, NG2-glia as Multipotent Neural Stem Cells: Fact or Fantasy?, Neuron, vol.70, issue.4, pp.26-2011
DOI : 10.1016/j.neuron.2011.05.013

URL : http://doi.org/10.1016/j.neuron.2011.05.013

W. Stallcup, The NG2 antigen, a putative lineage marker: Immunofluorescent localization in primary cultures of rat brain, Developmental Biology, vol.83, issue.1, 1981.
DOI : 10.1016/S0012-1606(81)80018-8

J. Levine and J. Card, Light and electron microscopic localization of a cell surface antigen (NG2) in the rat cerebellum: association with smooth protoplasmic astrocytes, J Neurosci, 1987.

M. Dawson, NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS, Molecular and Cellular Neuroscience, vol.24, issue.2, 2003.
DOI : 10.1016/S1044-7431(03)00210-0

S. Kang, NG2+ CNS Glial Progenitors Remain Committed to the Oligodendrocyte Lineage in Postnatal Life and following Neurodegeneration, Neuron, vol.68, issue.4, 2010.
DOI : 10.1016/j.neuron.2010.09.009

Z. Su and Y. Yuan, Reactive Astrocytes Inhibit the Survival and Differentiation of Oligodendrocyte Precursor Cells by Secreted TNF-??, Journal of Neurotrauma, vol.28, issue.6, 2011.
DOI : 10.1089/neu.2010.1597

S. Wang and K. Young, White matter plasticity in adulthood, Neuroscience, vol.276, 2014.
DOI : 10.1016/j.neuroscience.2013.10.018

W. Macklin, Expression of myelin proteolipid and basic protein mRNAS in cultured cells, Journal of Neuroscience Research, vol.81, issue.1, 1986.
DOI : 10.1128/MCB.2.6.617

C. Demerens, Induction of myelination in the central nervous system by electrical activity., Proc Natl Acad Sci. 9 mars, 1996.
DOI : 10.1073/pnas.93.18.9887

E. Gibson, Neuronal Activity Promotes Oligodendrogenesis and Adaptive Myelination in the Mammalian Brain, Science, vol.28, issue.1, 2014.
DOI : 10.1523/JNEUROSCI.4178-07.2008

H. Wake, F. Ortiz, D. Woo, P. Lee, M. Angulo et al., Nonsynaptic junctions on myelinating glia promote preferential myelination of electrically active axonsSynaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo, Nat Neurosci, 2015.

J. Hines, Neuronal activity biases axon selection for myelination in vivo, Nature Neuroscience, vol.16, issue.5, 2015.
DOI : 10.1523/JNEUROSCI.0981-05.2005

S. Bengtsson, Extensive piano practicing has regionally specific effects on white matter development, Nature Neuroscience, vol.125, issue.9
DOI : 10.1016/0165-3806(95)00193-X

I. Mckenzie, Motor skill learning requires active central myelination, Science, vol.32, issue.1
DOI : 10.1002/gene.10023

D. Bergles, Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus, Nature, vol.405, issue.6783, 2000.
DOI : 10.1038/35012083

J. Mangin and V. Gallo, The Curious Case of NG2 Cells: Transient Trend or Game Changer?, ASN Neuro, vol.16, issue.1, 2011.
DOI : 10.1038/nn1854

J. Mangin, Experience-dependent regulation of NG2 progenitors in the developing barrel cortexAlteration of synaptic connectivity of oligodendrocyte precursor cells following demyelination, Nat Neurosci. Cell Neurosci, vol.17, 2015.

M. Kukley, The Fate of Synaptic Input to NG2 Glial Cells: Neurons Specifically Downregulate Transmitter Release onto Differentiating Oligodendroglial CellsNMDA receptors are expressed in oligodendrocytes and activated in ischaemia, J Neurosci Nature, vol.22, 2005.

K. Pitman and K. Young, Activity-dependent calcium signalling in oligodendrocyte generation, The International Journal of Biochemistry & Cell Biology, vol.77, 2016.
DOI : 10.1016/j.biocel.2016.05.018

H. Wake, Control of Local Protein Synthesis and Initial Events in Myelination by Action Potentials, Science, vol.12, issue.11, 2011.
DOI : 10.1038/nn.2412

C. Haberlandt, Gray Matter NG2 Cells Display Multiple Ca2+-Signaling Pathways and Highly Motile Processes, PLoS ONE, vol.233, issue.3, 2011.
DOI : 10.1371/journal.pone.0017575.s006

URL : http://doi.org/10.1371/journal.pone.0017575

M. Zonouzi, Bidirectional plasticity of calcium-permeable AMPA receptors in oligodendrocyte lineage cells, Nature Neuroscience, vol.22, issue.11, 2011.
DOI : 10.1038/sj.cdd.4401785

URL : https://hal.archives-ouvertes.fr/hal-00686245

C. Agresti, Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development". Glia. 15 avr, 2005.
DOI : 10.1002/glia.20160

V. Cheli, Voltage-gated Ca++ entry promotes oligodendrocyte progenitor cell maturation and myelination in vitro, Experimental Neurology, vol.265, 2015.
DOI : 10.1016/j.expneurol.2014.12.012

S. Kirischuk, channels in cells of the oligodendrocyte lineage, Glia, vol.6, issue.1, 1995.
DOI : 10.1016/0896-6273(91)90243-S

S. Lin, B. Defort, M. Audinat, E. Angulo, and M. , Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampusFunctional alpha 7-containing nicotinic receptors of NG2-expressing cells in the hippocampus, Nat Neurosci. janv Glia, vol.123, 2004.

M. Berridge, The versatility and universality of calcium signalling, Nat Rev Mol Cell Biol. oct, 2000.

D. Fulton, Regulation of L-type Ca++ currents and process morphology in white matter oligodendrocyte precursor cells by golli-myelin proteins, Glia, vol.9, issue.1, 2010.
DOI : 10.1007/978-1-4419-9254-3_7

V. Cheli, Voltage-gated Ca++ entry promotes oligodendrocyte progenitor cell maturation and myelination in vitro, Experimental Neurology, vol.265, 2015.
DOI : 10.1016/j.expneurol.2014.12.012

P. Paez, Golli myelin basic proteins regulate oligodendroglial progenitor cell migration through voltage-gated Ca++ influx, J Neurosci Off J Soc Neurosci, 2009.
DOI : 10.1523/jneurosci.5806-08.2009

URL : http://www.jneurosci.org/content/jneuro/29/20/6663.full.pdf

P. Paez, Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain". Glia, 2012.

P. Paez, Modulation of Canonical Transient Receptor Potential Channel 1 in the Proliferation of Oligodendrocyte Precursor Cells by the Golli Products of the Myelin Basic Protein Gene, Journal of Neuroscience, vol.31, issue.10, 2011.
DOI : 10.1523/JNEUROSCI.4424-10.2011

P. Maldonado and M. Angulo, Multiple Modes of Communication between Neurons and Oligodendrocyte Precursor Cells, The Neuroscientist, vol.125, issue.15, 2015.
DOI : 10.1038/nn.2942

C. Grienberger and A. Konnerth, Imaging Calcium in Neurons, Neuron, vol.73, issue.5, 2012.
DOI : 10.1016/j.neuron.2012.02.011

R. Franklin, Why does remyelination fail in multiple sclerosis?, Nature Reviews Neuroscience, vol.105, issue.9, 2002.
DOI : 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1

M. Kipp, Endogeneous remyelination: findings in human studiesNeuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors, CNS Neurol Disord Drug Targets Nat Commun, 2015.

W. Huang, Novel NG2-CreERT2 knock-in mice demonstrate heterogeneous differentiation potential of NG2 glia during development, Glia, vol.138, issue.Pt 1, 2014.
DOI : 10.1242/dev.047951

H. Zariwala, A Cre-Dependent GCaMP3 Reporter Mouse for Neuronal Imaging In Vivo, Journal of Neuroscience, vol.32, issue.9, pp.29-2012
DOI : 10.1523/JNEUROSCI.4469-11.2012

R. Sturrock, MYELINATION OF THE MOUSE CORPUS CALLOSUM, Neuropathology and Applied Neurobiology, vol.31, issue.6, 1980.
DOI : 10.1002/cne.901700208

E. Vereyken, An in vitro model for de-and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures". Glia, 2009.

S. Ousman and S. David, Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord, Glia. mars, 2000.

N. Hamilton, Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-glia, Glia, vol.10, issue.1, 2010.
DOI : 10.1002/glia.20902

E. Alberdi, Calcium and glial cell death. Cell Calcium". sept, 2005.
DOI : 10.1016/j.ceca.2005.06.020

URL : http://www.ehu.es/neurobiology/data/Alberdi-et-al-2005-CellCalcium.pdf

P. Simpson, Release Sites in Oligodendrocyte Processes, Journal of Biological Chemistry, vol.122, issue.150, 1997.
DOI : 10.1042/bj2850681

T. Chen, Ultrasensitive fluorescent proteins for imaging neuronal activityIntracellular signals and cytoskeletal elements involved in oligodendrocyte progenitor migration, Glia. mars, 1999.